Literature DB >> 3118348

Testicular dysfunction in men with sickle cell disease.

D N Osegbe1, O O Akinyanju.   

Abstract

In order to assess the role of the gonads and anterior pituitary gland in the production of poor quality semen of males with homozygous sickle cell disease (SCD) serum gonadotrophins, namely follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin and serum testosterone, were assayed radioimmunologically in 33 men with sickle cell disease and in 29 age-matched normal control subjects. Our results show a significantly lower mean serum testosterone, a higher mean FSH and prolactin in SCD subjects than in normal controls. No single SCD subject had significantly low serum testosterone associated with low FSH, LH or prolactin. The tendency for higher gonadotrophins associated with lower testosterone in subjects with SCD suggests that the hypothalamic/pituitary function in these patients is intact and that the primary fault leading to poor sperm production lies in the testes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118348      PMCID: PMC2428240          DOI: 10.1136/pgmj.63.736.95

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

1.  Heights, weights, and skeletal age of Jamaican adolescents with sickle cell anaemia.

Authors:  M T Ashcroft; G R Serjeant; P Desai
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

2.  Testicular function in sickle cell disease.

Authors:  G Friedman; R Freeman; R Bookchin; R Boyar; G Murthy; L Hellman
Journal:  Fertil Steril       Date:  1974-12       Impact factor: 7.329

3.  Fertility in males with sickle cell disease.

Authors:  D N Osegbe; O Akinyanju; E O Amaku
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

4.  Endocrine function and haemoglobinopathies: relation between the sickle cell gene and circulating plasma levels of testosterone, luteinising hormone (LH) and follicle stimulating hormone (FSH) in adult males.

Authors:  O A Dada; E U Nduka
Journal:  Clin Chim Acta       Date:  1980-08-04       Impact factor: 3.786

5.  Hyperprolactinemic male infertility.

Authors:  S Segal; W Z Polishuk; M Ben-David
Journal:  Fertil Steril       Date:  1976-12       Impact factor: 7.329

6.  Dynamic evaluation of prolactin secretion in patients with oligospermia: effects of treatment with metergoline.

Authors:  A Masala; G Delitala; S Alagna; L Devilla; P P Rovasio; G Lotti
Journal:  Fertil Steril       Date:  1979-01       Impact factor: 7.329

7.  Clomiphene-responsive hypogonadism in sickle cell anemia.

Authors:  C S Landefeld; M Schambelan; S L Kaplan; S H Embury
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

8.  Gonadal function abnormalities in sickle cell anemia. Studies in adult male patients.

Authors:  A A Abbasi; A S Prasad; J Ortega; E Congco; D Oberleas
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

  8 in total
  11 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis.

Authors:  B Musicki; S Karakus; W Akakpo; F H Silva; J Liu; H Chen; B R Zirkin; A L Burnett
Journal:  Andrology       Date:  2017-11-16       Impact factor: 3.842

3.  Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease?

Authors:  Belinda F Morrison; Uzoma A Anele; Marvin E Reid; Wendy A Madden; Zhaoyong Feng; Arthur L Burnett
Journal:  Int Urol Nephrol       Date:  2014-11-05       Impact factor: 2.370

4.  Hypogonadism in patients with sickle cell disease: central or peripheral?

Authors:  A Taddesse; I L Woldie; P Khana; P S Swerdlow; J-W Chu; J Abrams; A-B Abou-Samra
Journal:  Acta Haematol       Date:  2012-06-06       Impact factor: 2.195

Review 5.  Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care.

Authors:  Robert Sheppard Nickel; Jacqueline Y Maher; Michael H Hsieh; Meghan F Davis; Matthew M Hsieh; Lydia H Pecker
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.964

6.  Effects of pharmacologically induced Leydig cell testosterone production on intratesticular testosterone and spermatogenesis†.

Authors:  Jin-Yong Chung; Sean Brown; Haolin Chen; June Liu; Vassilios Papadopoulos; Barry Zirkin
Journal:  Biol Reprod       Date:  2020-02-14       Impact factor: 4.285

7.  Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.

Authors:  Mário Angelo Claudino; Kleber Yotsumoto Fertrin
Journal:  Anemia       Date:  2012-06-13

8.  Mechanism of testosterone deficiency in the transgenic sickle cell mouse.

Authors:  Biljana Musicki; Yuxi Zhang; Haolin Chen; Terry R Brown; Barry R Zirkin; Arthur L Burnett
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

9.  Predictors of abnormal bone mass density in adult patients with homozygous sickle-cell disease.

Authors:  Taysir S Garadah; Adla B Hassan; Ahmed A Jaradat; Diab E Diab; Hiba O Kalafalla; Adel K Kalifa; Reginald P Sequeira; Abdul Hameed A Alawadi
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2015-05-07

10.  Does blood transfusion affect pituitary gonadal axis and sperm parameters in young males with sickle cell disease?

Authors:  Ashraf T Soliman; Mohamed Yasin; Ahmed El-Awwa; Mohamed O Abdelrahman; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.